Pharmacological Triggers of Takotsubo Cardiomyopathy: An Updated
Review of Evidence and Recommendations

S.      Arunkumar; K.      Jegaverrapandi
Abstract

Background: Previous publications in 2011, 2016, and 2022 have presented lists of drugs associated with takotsubo cardiomyopathy (TCM). This review aims to provide updated drug lists that have been reported as potential causes of TCM.
Methods: Following the same methodology employed in previous reviews, a detailed investigation was carried out in the PubMed/Medline database from June 2022 to July 2023 to identify drug-induced TCM (DITC) case reports. Various search terms related to the drug-induced transient left ventricular ballooning syndrome, ampulla cardiomyopathy, apical ballooning syndrome, drug-induced broken heart syndrome, drug triggered takotsubo cardiomyopathy, takotsubo cardiomyopathy, and iatrogenic takotsubo cardiomyopathy were utilized. Filters for fulltext availability, case reports, human studies, and English language were applied. Articles reporting drugs associated with TCM development were included in the analysis.
Results: Foremost 192 case reports were initially identified, with 75 drugs meeting the inclusion criteria after a thorough review. The latest revision identified seven drugs that might lead to TCM, with four drugs (57.14%) already reported in previous reviews and three drugs (42.86%) newly identified. Consequently, the updated drug list potentially triggering TCM in 2023 comprises a sum of 75 drugs.
Conclusion: The recent 75 drugs provided additional evidence linking to TCM development. The updated list predominantly includes drugs that induce sympathetic overstimulation, although some drugs on the list have unclear associations with sympathetic nervous system activation.
Graphical Abstract

[1]
Assad J, Femia G, Pender P, Badie T, Rajaratnam R. Takotsubo syndrome: A review of presentation, diagnosis and management. Clin Med Insights Cardiol  2022; 16.
 [http://dx.doi.org/10.1177/11795468211065782] [PMID: 35002350]

[2]
Fan X, Yang G, Kowitz J, Akin I, Zhou X, El-Battrawy I. Takotsubo syndrome: Translational implications and pathomechanisms. Int J Mol Sci  2022; 23(4): 1951.
 [http://dx.doi.org/10.3390/ijms23041951] [PMID: 35216067]

[3]
Kido K, Guglin M. Drug-induced takotsubo cardiomyopathy. J Cardiovasc Pharmacol Ther  2017; 22(6): 552-63.
 [http://dx.doi.org/10.1177/1074248417708618] [PMID: 28490198]

[4]
Shah RM, Shah M, Shah S, Li A, Jauhar S. Takotsubo syndrome and COVID-19: Associations and implications. Curr Probl Cardiol  2021; 46(3): 100763.
 [http://dx.doi.org/10.1016/j.cpcardiol.2020.100763] [PMID: 33360674]

[5]
Matta AG, Carrié D. Epidemiology, pathophysiology, diagnosis, and principles of management of takotsubo cardiomyopathy: A review. Med Sci Monit  2023; 29: e939020.
 [http://dx.doi.org/10.12659/MSM.939020] [PMID: 36872594]

[6]
Amariles P. A comprehensive literature search: Drugs as possible triggers of Takotsubo cardiomyopathy. Curr Clin Pharmacol  2011; 6(1): 1-11.
 [http://dx.doi.org/10.2174/157488411794941340] [PMID: 21235467]

[7]
Amariles P, Cifuentes L. Drugs as Possible triggers of takotsubo cardiomyopathy: A comprehensive literature search - update 2015. Curr Clin Pharmacol  2016; 11(2): 95-109.
 [http://dx.doi.org/10.2174/1574884711666160405105841] [PMID: 27049039]

[8]
Lopera V, Pereañez JA, Amariles PJ. Drugs as possible triggers of takotsubo cardiomyopathy- update 2022: Systematic review. Curr Vasc Pharmacol  2023; 21(5): 304-15.
 [http://dx.doi.org/10.2174/1570161121666230517121037] [PMID: 37198980]

[9]
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ  2021; 372(71): n71.
 [http://dx.doi.org/10.1136/bmj.n71] [PMID: 33782057]

[10]
Popa-Fotea NM, Micheu MM, Mihai C, State R, Tincu R, Scafa-Udriste A. Takotsubo cardiomyopathy and β-blocker poisoning: A case report. Medicina 2022; 58(12): 1777.
 [http://dx.doi.org/10.3390/medicina58121777] [PMID: 36556979]

[11]
Singhal S, Patel G, Singh RB, Goyal A, Avgush K, Koka J. Atezolizumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis and Takotsubo cardiomyopathy. BMJ Case Rep  2022; 15(7): e250662.
 [http://dx.doi.org/10.1136/bcr-2022-250662] [PMID: 35793858]

[12]
Sugawara M, Okada S, Kanda M, Iseki T, Sakaida E, Kobayashi Y. Anagrelide-associated cardiomyopathy and heart failure in a patient with essential thrombocythemia: A case report and literature review. Intern Med  2022; 61(21): 3293-9.
 [http://dx.doi.org/10.2169/internalmedicine.9090-21] [PMID: 35342135]

[13]
Konsek-Komorowska SJ, Cygański P, Rynkiewicz A. Takotsubo cardiomyopathy triggered by a single dose of flecainide in patient with focal atrial tachycardia. Acta Cardiol  2022; 77(9): 848-51.
 [http://dx.doi.org/10.1080/00015385.2022.2030567] [PMID: 35067182]

[14]
Garcia S, Terroso G, Martins E, Pimenta S, Costa L, Bernardes M. Takotsubo syndrome in a rheumatoid arthritis patient under tofacitinib: A case report. Reumatol Clin 2021.
 [http://dx.doi.org/10.1016/j.reuma.2021.06.003]

[15]
Sagray E, Johnson JN, Anderson JH. Dobutamine-induced Takotsubo syndrome in a paediatric heart transplant patient. Cardiol Young  2023; 33(4): 646-8.
 [http://dx.doi.org/10.1017/S1047951122002311] [PMID: 35899969]

[16]
Visclosky T, Klekowski N, Sikavitsas A. Pediatric Takotsubo cardiomyopathy resulting from clonidine overdose. Am J Emerg Med  2023; 63: 179.e1-4.
 [http://dx.doi.org/10.1016/j.ajem.2022.09.037] [PMID: 36216626]

[17]
Pathak S, Dubey M, Goel N. Takotsubo cardiomyopathy due to cephalosporin anaphylaxis under general anaesthesia. Indian J Anaesth  2016; 60(3): 215-6.
 [http://dx.doi.org/10.4103/0019-5049.177870] [PMID: 27053788]

[18]
Bhakta S, Flick SM, Cooney MM, et al. Myocardial stunning following combined modality combretastatin-based chemotherapy: Two case reports and review of the literature. Clin Cardiol  2009; 32(12): E80-4.
 [http://dx.doi.org/10.1002/clc.20685] [PMID: 20014213]

[19]
Koh AS, Kok H, Chua T, Keng F. Takotsubo cardiomyopathy following dipyridamole pharmacologic stress. Ann Nucl Med  2010; 24(6): 497-500.
 [http://dx.doi.org/10.1007/s12149-010-0371-0] [PMID: 20340053]

[20]
Meaudre E, Barbou F, Sallaberry M, Cantais E, Petit D, Palmier B. Rapid reversal of global left ventricular dysfunction after accidental injection of 0.75 mg epinephrine in a 20-year-old patient. Acta Anaesthesiol Scand  2004; 48(7): 914-6.
 [http://dx.doi.org/10.1111/j.0001-5172.2004.00428.x] [PMID: 15242440]

[21]
Citro R, Pascotto M, Provenza G, Gregorio G, Bossone E. Transient left ventricular ballooning (tako-tsubo cardiomyopathy) soon after intravenous ergonovine injection following caesarean delivery. Int J Cardiol  2010; 138(2): e31-4.
 [http://dx.doi.org/10.1016/j.ijcard.2008.06.041] [PMID: 18707778]

[22]
Kwon SA, Yang JH, Kim MK, et al. A case of Takotsubo cardiomyopathy in a patient with Iatrogenic thyrotoxicosis. Int J Cardiol  2010; 145(3): e111-3.
 [http://dx.doi.org/10.1016/j.ijcard.2009.06.040] [PMID: 19628289]

[23]
Ker J, Van Wyk CJ. A case of takotsubo cardiomyopathy precipitated by lumiracoxib, a selective COX-2 inhibitor. Cardiovasc J Afr  2007; 18(6): 383-4.
 [PMID: 18092115]

[24]
Jefic D, Koul D, Boguszewski A, Martini W. Transient left ventricular apical ballooning syndrome caused by abrupt metoprolol withdrawal. Int J Cardiol  2008; 131(1): e35-7.
 [http://dx.doi.org/10.1016/j.ijcard.2007.07.060] [PMID: 17949833]

[25]
De Roock S, Beauloye C, De Bauwer I, et al. tako tsubo syndrome following nortriptyline overdose. Clin Toxicol  2008; 46(5): 475-8.
 [http://dx.doi.org/10.1080/15563650701519786] [PMID: 18568805]

[26]
White AJ, LaGerche A, Toner GC, Whitbourn RJ. Apical ballooning syndrome during treatment with a vascular endothelial growth factor receptor antagonist. Int J Cardiol  2009; 131(3): e92-4.
 [http://dx.doi.org/10.1016/j.ijcard.2007.07.066] [PMID: 17920711]

[27]
Proietti R, Rognoni A, Ardizzone F, Maccio S, Santagostino A, Rognoni G. Atypical Takotsubo syndrome during anagrelide therapy. J Cardiovasc Med  2009; 10(7): 546-9.
 [http://dx.doi.org/10.2459/JCM.0b013e32832b7f08] [PMID: 19395976]

[28]
Sandhu G, Servetnyk Z, Croitor S, Herzog E. Atropine aggravates signs and symptoms of Takotsubo cardiomyopathy. Am J Emerg Med  2010; 28(2): 258.e5-7.
 [http://dx.doi.org/10.1016/j.ajem.2009.06.011] [PMID: 20159414]

[29]
Parodi G, Antoniucci D. Transient left ventricular apical ballooning syndrome after inadvertent epidural administration of potassium chloride. Int J Cardiol  2008; 124(1): e14-5.
 [http://dx.doi.org/10.1016/j.ijcard.2006.11.161] [PMID: 17328974]

[30]
Cherian J, Kothari S, Angelis D, Atef A, Downey B, Kirkpatrick J Jr. Atypical takotsubo cardiomyopathy: Dobutamine-precipitated apical ballooning with left ventricular outflow tract obstruction. Tex Heart Inst J  2008; 35(1): 73-5.
 [PMID: 18427659]

[31]
Vasconcelos Filho FJ, Gomes CA, Queiroz OA, Barreto JE. Dobutamine stress echocardiography-induced broken heart syndrome (Takotsubo Syndrome). Arq Bras Cardiol  2009; 93(1): e5-7.

[32]
Silberbauer J, Hong P, Lloyd G. Takotsubo cardiomyopathy (left ventricular ballooning syndrome) induced during dobutamine stress echocardiography. Eur J Echocardiogr  2007; 9(1): 136-8.
 [http://dx.doi.org/10.1016/j.euje.2007.04.006] [PMID: 17905663]

[33]
Bergman BR, Reynolds HR, Skolnick AH, Castillo D. A case of apical ballooning cardiomyopathy associated with duloxetine. Ann Intern Med  2008; 149(3): 218-9.
 [http://dx.doi.org/10.7326/0003-4819-149-3-200808050-00021] [PMID: 18678857]

[34]
Kobayashi N, Hata N, Yokoyama S, Shinada T, Shirakabe A, Mizuno K. A case of Takotsubo cardiomyopathy during 5-fluorouracil treatment for rectal adenocarcinoma. J Nippon Med Sch  2009; 76(1): 27-33.
 [http://dx.doi.org/10.1272/jnms.76.27] [PMID: 19305108]

[35]
Christoph M, Ebner B, Stolte D, et al. Broken heart syndrome: Tako Tsubo cardiomyopathy associated with an overdose of the serotonin-norepinephrine reuptake inhibitor Venlafaxine. Eur Neuropsychopharmacol  2010; 20(8): 594-7.
 [http://dx.doi.org/10.1016/j.euroneuro.2010.03.009] [PMID: 20451358]

[36]
Litvinov IV, Kotowycz MA, Wassmann S. Iatrogenic epinephrine-induced reverse Takotsubo cardiomyopathy: direct evidence supporting the role of catecholamines in the pathophysiology of the “broken heart syndrome”. Clin Res Cardiol  2009; 98(7): 457-62.
 [http://dx.doi.org/10.1007/s00392-009-0028-y] [PMID: 19513776]

[37]
Sato Y, Tanaka M, Nishikawa T. Reversible catecholamine-induced cardiomyopathy by subcutaneous injections of epinephrine solution in an anesthetized patient. Anesthesiology  2000; 92(2): 615-9.
 [http://dx.doi.org/10.1097/00000542-200002000-00048] [PMID: 10691253]

[38]
Alsidawi S, Muth J, Wilkin J. Adderall induced inverted-Takotsubo cardiomyopathy. Catheter Cardiovasc Interv  2011; 78(6): 910-3.
 [http://dx.doi.org/10.1002/ccd.23036] [PMID: 21567882]

[39]
Y-Hassan S, Jernberg T. Bromocriptine-induced coronary spasm caused acute coronary syndrome, which triggered its own clinical twin--Takotsubo syndrome. Cardiology  2011; 119(1): 1-6.
 [http://dx.doi.org/10.1159/000329349] [PMID: 21757900]

[40]
Klag T, Cantara G, Ong P, Kaufmann M, Sechtem U, Athanasiadis A. Epicardial coronary artery spasm as cause of capecitabine-induced tako tsubo cardiomyopathy. Clin Res Cardiol  2014; 103(3): 247-50.
 [http://dx.doi.org/10.1007/s00392-013-0636-4] [PMID: 24276117]

[41]
Sun RH, Hu BC, Li Q. Stress-induced cardiomyopathy complicated by multiple organ failure following cephalosporin-induced anaphylaxis. Intern Med  2012; 51(8): 895-9.
 [http://dx.doi.org/10.2169/internalmedicine.51.6887] [PMID: 22504246]

[42]
Goel S, Sharma A, Garg A, Chandra A, Shetty V. Chemotherapy induced Takotsubo cardiomyopathy. World J Clin Cases  2014; 2(10): 565-8.
 [http://dx.doi.org/10.12998/wjcc.v2.i10.565] [PMID: 25325068]

[43]
Sarkar S, Arguelles E, de Elia C. Takosubo cardiomyopathy presenting as a non-ST segment elevation myocardial infarction in the setting of cocaine use and asthma exacerbation. Int J Cardiol  2013; 168(1): e1-2.
 [http://dx.doi.org/10.1016/j.ijcard.2013.04.191] [PMID: 23684595]

[44]
Mubarak G, Haddadin M, Samra B, Luhrs C, Taiwo E. Doxorubicin-associated takotsubo cardiomyopathy in a patient with adult T-cell leukemia/lymphoma. Clin Case Rep  2019; 7(12): 2466-71.
 [http://dx.doi.org/10.1002/ccr3.2504] [PMID: 31893081]

[45]
Sasaki H, Yumoto K, Nanao T, et al. Cardiogenic shock due to takotsubo cardiomyopathy associated with serotonin syndrome. J Cardiol Cases  2013; 7(1): e1-3.
 [http://dx.doi.org/10.1016/j.jccase.2012.07.011] [PMID: 30533105]

[46]
Goyal SK, Gera C, Singla M, Kumar N. Desvenlafaxine overdose-induced toxic cardiomyopathy and acute left ventricular failure: A case report. Indian J Psychol Med  2018; 40(1): 99-100.
 [http://dx.doi.org/10.4103/IJPSYM.IJPSYM_397_17] [PMID: 29403141]

[47]
Power HS. Under-diagnosis of takotsubo cardiomyopathy increases risk of adverse events: A case study. Cureus  2019; 11(9): e5749.
 [http://dx.doi.org/10.7759/cureus.5749] [PMID: 31723510]

[48]
Gabriel L, Chenu P, Guédès A, et al. A possible association between takotsubo cardiomyopathy and treatment with flecainide. Int J Cardiol  2011; 147(1): 173-5.
 [http://dx.doi.org/10.1016/j.ijcard.2010.12.023] [PMID: 21208670]

[49]
Battineni A, Mullaguri N, Thanki S, Chockalingam A, Govindarajan R. A case report of recurrent takotsubo cardiomyopathy in a patient during myasthenia crisis. Case Rep Crit Care  2017; 2017: 1-5.
 [http://dx.doi.org/10.1155/2017/5702075] [PMID: 29201468]

[50]
Mehta NK, Aurigemma G, Rafeq Z, Starobin O. Reverse takotsubo cardiomyopathy: After an episode of serotonin syndrome. Tex Heart Inst J  2011; 38(5): 568-72.
 [PMID: 22163138]

[51]
Ali A, Niazi A, Minko P, et al. A Case of takotsubo cardiomyopathy after local anesthetic and epinephrine infiltration. Cureus  2018; 10(8): e3173.
 [http://dx.doi.org/10.7759/cureus.3173] [PMID: 30357060]

[52]
Kitami M, Oizumi H, Kish SJ, Furukawa Y. Takotsubo cardiomyopathy associated with lithium intoxication in bipolar disorder: A case report. J Clin Psychopharmacol  2014; 34(3): 410-1.
 [http://dx.doi.org/10.1097/JCP.0b013e3182a95a27] [PMID: 24699038]

[53]
Medved S, Ostojić Z, Jurin H, Medved V. Takotsubo cardiomyopathy after the first electroconvulsive therapy regardless of adjuvant beta-blocker use: A case report and literature review. Croat Med J  2018; 59(6): 307-12.
 [http://dx.doi.org/10.3325/cmj.2018.59.307] [PMID: 30610773]

[54]
Sacco A, Morici N, Belli O, Bossi I, Mafrici A, Klugmann S. Tako-Tsubo like syndrome triggered by meperidine. Med J Malaysia  2011; 66(5): 520-1.
 [PMID: 22390119]

[55]
Ramanath VS, Andrus BW, Szot CR, Kaplan AV, Robb JF. Takotsubo cardiomyopathy after midodrine therapy. Tex Heart Inst J  2012; 39(1): 158-9.
 [PMID: 22412259]

[56]
Forman MB, Sutej PG, Jackson EK. Hypertension, tachycardia, and reversible cardiomyopathy temporally associated with milnacipran use. Tex Heart Inst J  2011; 38(6): 714-8.
 [PMID: 22199446]

[57]
Sarcon A, Ghadri JR, Wong G, Lüscher TF, Templin C, Amsterdam E. Takotsubo cardiomyopathy associated with opiate withdrawal. QJM  2014; 107(4): 301-2.
 [http://dx.doi.org/10.1093/qjmed/hct219] [PMID: 24170890]

[58]
Placci A, Sella G, Bellanti G, Margheri M. Anabolic androgenic steroid-induced Takotsubo cardiomyopathy. BMJ Case Rep  2015; 2015((mar24 1)): bcr2014209089.
 [http://dx.doi.org/10.1136/bcr-2014-209089] [PMID: 25804946]

[59]
Ioscovich A, Kolker S, Tzivoni D, Rosenmann D, Meyler S. Neostigmine induced coronary artery spasm: A case report and literature review. J Anaesthesiol Clin Pharmacol  2017; 33(3): 402-5.
 [http://dx.doi.org/10.4103/0970-9185.173337] [PMID: 29109645]

[60]
Desai A, Noor A, Joshi S, Kim AS. Takotsubo cardiomyopathy in cancer patients. Cardiooncology  2019; 5(1): 7.
 [http://dx.doi.org/10.1186/s40959-019-0042-9] [PMID: 32154014]

[61]
Ng KH, Dearden C, Gruber P. Rituximab-induced Takotsubo syndrome: More cardiotoxic than it appears? BMJ Case Rep  2015; 2015(mar02 1): bcr2014208203.
 [http://dx.doi.org/10.1136/bcr-2014-208203] [PMID: 25733089]

[62]
Cabaton J, Rondelet B, Gergele L, Besnard C, Piriou V. Tako tsubo syndrome after anaphylaxis caused by succinylcholine during general anaesthesia]. Ann Fr Anesth Reanim  2008; 27(10): 854-7.
 [http://dx.doi.org/10.1016/j.annfar.2008.08.006] [PMID: 18829243]

[63]
Courand PY, Jenck S, Cassar E, David E, Carrabin N, Lantelme P. Tako tsubo cardiomyopathy probably associated with administration of sulprostone following cesarean delivery. Rev Esp Cardiol  2012; 65(8): 770-1.
 [http://dx.doi.org/10.1016/j.rec.2011.10.029]

[64]
Numico G, Sicuro M, Silvestris N, et al. Takotsubo syndrome in a patient treated with sunitinib for renal cancer. J Clin Oncol  2012; 30(24): e218-20.
 [http://dx.doi.org/10.1200/JCO.2012.42.4911] [PMID: 22802320]

[65]
Dziewierz A, Olszanecka A, Wiliński J. Inverted takotsubo cardiomyopathy in a patient with essential thrombocythemia exposed to anagrelide and phentermine. Int J Cardiol  2012; 160(2): e31-2.
 [http://dx.doi.org/10.1016/j.ijcard.2012.01.045] [PMID: 22406466]

[66]
Di Micoli A, Buccione D, Degli Esposti D, et al. Terlipressin infusion induces Tako-Tsubo syndrome in a cirrhotic man with hepato-renal syndrome. Intern Emerg Med  2011; 6(5): 437-40.
 [http://dx.doi.org/10.1007/s11739-011-0534-6] [PMID: 21327551]

[67]
Coen M, Rigamonti F, Roth A, Koessler T. Chemotherapy-induced Takotsubo cardiomyopathy, a case report and review of the literature. BMC Cancer  2017; 17(1): 394.
 [http://dx.doi.org/10.1186/s12885-017-3384-4] [PMID: 28578653]

[68]
Garg J, Aronow WS, Devabhaktuni S, Ahmad H. Takotsubo syndrome (or apical ballooning syndrome) secondary to Zolmitriptan. Am J Ther  2015; 22(2): e52-6.
 [http://dx.doi.org/10.1097/01.mjt.0000433938.07244.05] [PMID: 24100257]

[69]
Kocaoglu I, Gökaslan S, Karagöz A, Sahin D, Ucar Ö, Aydogdu S. Zolmitriptan-induced acute myocardial infarction. Cardiol J  2012; 19(1): 76-8.
 [http://dx.doi.org/10.5603/CJ.2012.0011] [PMID: 22298171]

[70]
Laínez B, Ureña M, Alvarez V, Lezaun R. Iatrogenic tako-tsubo cardiomyopathy secondary to catecholamine administration. Rev Esp Cardiol  2009; 62(12): 1498-9.
 [http://dx.doi.org/10.1016/S0300-8932(09)73140-9] [PMID: 20038421]

[71]
Spina R, Song N, Kathir K, Muller DWM, Baron D. Takotsubo cardiomyopathy following unintentionally large subcutaneous adrenaline injection: A case report. Eur Heart J Case Rep  2018; 22: yty043.
 [http://dx.doi.org/10.1093/ehjcr/yty043]

[72]
Quick S, Quick C, Schneider R, et al. Guillain-Barré syndrome and catecholamine therapy. A potential risk for developing takotsubo cardiomyopathy? Int J Cardiol  2013; 165(3): e43-4.
 [http://dx.doi.org/10.1016/j.ijcard.2012.10.083] [PMID: 23181996]

[73]
Lee A, Nguyen P. Takotsubo cardiomyopathy due to systemic absorption of intraocular phenylephrine. Heart Lung Circ  2016; 25(12): e159-61.
 [http://dx.doi.org/10.1016/j.hlc.2016.06.1204] [PMID: 27475260]

[74]
Law C, Khaliq A, Guglin M. Reversible cardiogenic shock due to catecholamine-induced cardiomyopathy: A variant of takotsubo? Am J Emerg Med  2013; 31(11): 1621.e1-3.
 [http://dx.doi.org/10.1016/j.ajem.2013.05.042] [PMID: 23810075]

[75]
Parsa SA, Khaheshi I, Memaryan M, Naderian M. Takotsubo cardiomyopathy following recurrent doses of albuterol due to asthma attack: A very rare case report. Fut Cardiol  2016; 12(6): 609-12.
 [http://dx.doi.org/10.2217/fca-2016-0040] [PMID: 27759421]

[76]
Ovadia D, Esquenazi Y, Bucay M, Bachier CR. Association between takotsubo cardiomyopathy and axitinib: Case report and review of the literature. J Clin Oncol  2015; 33(1): e1-3.
 [http://dx.doi.org/10.1200/JCO.2013.48.7280] [PMID: 24567431]

[77]
Jamshidi N, Clark D, Murnion B. Recurrent takotsubo cardiomyopathy associated with opioid withdrawal during buprenorphine induction. Cardiovasc Toxicol  2021; 21(5): 349-53.
 [http://dx.doi.org/10.1007/s12012-020-09624-z] [PMID: 33481183]

[78]
Surmaitis RM, Khalid MM, Vearrier D, Greenberg MI. Takotsubo cardiomyopathy associated with buprenorphine precipitated withdrawal. Clin Toxicol  2018; 56(9): 863-4.
 [http://dx.doi.org/10.1080/15563650.2018.1437921] [PMID: 29433361]

[79]
Franco T, Khan A, Joshi V, Thomas B. Takotsubo cardiomyopathy in two men receiving bevacizumab for metastatic cancer. Ther Clin Risk Manag  2008; 4(6): 1367-70.
 [http://dx.doi.org/10.2147/TCRM.S3960] [PMID: 19337443]

[80]
Li Y, Tian W, Yue D, et al. Bevacizumab-induced mitochondrial dysfunction, endoplasmic reticulum stress, and ERk inactivation contribute to cardiotoxicity. Oxid Med Cell Longev  2021; 2021: 1-11.
 [http://dx.doi.org/10.1155/2021/5548130] [PMID: 33859777]

[81]
Nakagawa N, Fukawa N, Tsuji K, Nakano N, Kato A. Takotsubo cardiomyopathy induced by dopamine infusion after carotid artery stenting. Int J Cardiol  2016; 205: 62-4.
 [http://dx.doi.org/10.1016/j.ijcard.2015.12.023] [PMID: 26716585]

[82]
Baldacci F, Vergallo A, Del Dotto P, et al. Occurrence of Takotsubo syndrome in a patient with Parkinson’s disease after entacapone add-on. Parkinsonism Relat Disord  2014; 20(11): 1313-4.
 [http://dx.doi.org/10.1016/j.parkreldis.2014.09.009] [PMID: 25258328]

[83]
Ozpelit E, Ozpelit ME, Akdeniz B, Göldeli Ö. Ergotamine-induced takotsubo cardiomyopathy. Am J Ther  2016; 23(2): e597-600.
 [http://dx.doi.org/10.1097/MJT.0000000000000030] [PMID: 25099482]

[84]
Melao F, Nunes JP, Vasconcelos M, et al. Stress-induced cardiomyopathy associated with ipratropium bromide therapy in a patient with chronic obstructive pulmonary disease. Rev Port Cardiol  2014; 33(3): 175.
 [http://dx.doi.org/10.1016/j.repc.2013.10.012]

[85]
Shah NR, Declouette B, Ansari-Gilani K, et al. High-dose interleukin-2 therapy related adverse events and implications on imaging. Diagn Interv Radiol  2021; 27(5): 684-9.
 [http://dx.doi.org/10.5152/dir.2021.20503] [PMID: 34559052]

[86]
Candilio L, Moon T, Sado D, Dworakowski R. Iatrogenic corticosteroids induced Takotsubo cardiomyopathy. Cardiovasc Revasc Med  2018; 19(4): 471-3.
 [http://dx.doi.org/10.1016/j.carrev.2017.09.013] [PMID: 29122525]

[87]
Auboire L, Alexandre J, Boccadamo V, Labbé C. Tako-tsubo syndrome induced by a polidecanol injection: A case report. Int J Cardiol  2016; 223: 418-9.
 [http://dx.doi.org/10.1016/j.ijcard.2016.08.196] [PMID: 27552562]

[88]
Kamada T, Hayashi M, Yokoi H, et al. Takotsubo cardiomyopathy with involvement of delayed-onset rhabdomyolysis and acute kidney injury after rosuvastatin treatment. Intern Med  2015; 54(1): 31-5.
 [http://dx.doi.org/10.2169/internalmedicine.54.3239] [PMID: 25742890]

[89]
Potter BJ, Gobeil F, Oiknine A, Laramée P. The first case of takotsubo cardiomyopathy associated with sodium tetradecyl sulphate sclerotherapy. Can J Cardiol  2010; 26(4): e146-8.
 [http://dx.doi.org/10.1016/S0828-282X(10)70373-1] [PMID: 20386776]

[90]
Yamamoto W, Nishihara T, Nakanishi K, et al. Takotsubo cardiomyopathy induced by very low-dose epinephrine contained in local anesthetics: A case report. Am J Case Rep  2021; 22: e932028.
 [http://dx.doi.org/10.12659/AJCR.932028] [PMID: 34174047]

[91]
Murthy A, Henien S, Mcpherson CA, Logue MA. Epinephrine use results in ‘stress’ cardiomyopathy. J Cardiol Cases  2015; 11(3): 85-7.
 [http://dx.doi.org/10.1016/j.jccase.2014.11.001] [PMID: 30546537]

[92]
Maes S, Dhooghe NSJJ, Schotte H, Cattoir S, Jacobs TF, Van Landuyt K. Takotsubo cardiomyopathy induced by epinephrine infiltration for liposuction: Broken heart syndrome. Aesthet Surg J  2019; 39(10): NP431-6.
 [http://dx.doi.org/10.1093/asj/sjz201] [PMID: 31504179]

[93]
Patankar GR, Donsky MS, Schussler JM. Delayed takotsubo cardiomyopathy caused by excessive exogenous epinephrine administration after the treatment of angioedema. Proc Bayl Univ Med Cent  2012; 25(3): 229-30.
 [http://dx.doi.org/10.1080/08998280.2012.11928833] [PMID: 22754120]

[94]
Keshtkar F, Dale OT, Bennett WO, Hall CE. Management of airway obstruction with nebulised adrenaline resulting in takotsubo cardiomyopathy: Case report. J Laryngol Otol  2016; 130(9): 883-6.
 [http://dx.doi.org/10.1017/S0022215116008288] [PMID: 27377118]

[95]
Rader T, Bailey K, Flora AS. Iatrogenic takotsubo cardiomyopathy. Am J Ther  2018; 25(6): e695-8.
 [http://dx.doi.org/10.1097/MJT.0000000000000707] [PMID: 30398995]

[96]
Scheiba N, Viedt-Suelmann C, Schäkel K. Tako-tsubo cardiomyopathy after a hymenoptera sting and treatment with catecholamines. Acta Derm Venereol  2011; 91(5): 593-4.
 [http://dx.doi.org/10.2340/00015555-1119] [PMID: 21547339]

[97]
Nazir S, Melnick S, Lohani S, Lloyd B. Rare case of stress cardiomyopathy due to intramuscular epinephrine administration. BMJ Case Rep  2016; 2016: bcr2016215691.
 [http://dx.doi.org/10.1136/bcr-2016-215691] [PMID: 27268785]

[98]
Koo MS, Lee JW, Kim DH, Sir JJ, Kim JM. Inverted stress cardiomyopathy during monitored anesthesia care for endoscopic sinus surgery. Korean J Anesthesiol  2013; 65(6 Suppl.): S79-81.
 [http://dx.doi.org/10.4097/kjae.2013.65.6S.S79] [PMID: 24478883]

[99]
Santos JRU, Brofferio A, Viana B, Pacak K. Catecholamine-induced cardiomyopathy in pheochromocytoma: How to manage a rare complication in a rare disease? Horm Metab Res  2019; 51(7): 458-69.
 [http://dx.doi.org/10.1055/a-0669-9556] [PMID: 30227459]

[100]
Khalid N, Ahmad SA, Shlofmitz E, Chhabra L. Pathophysiology of takotsubo syndrome. In: StatPearls. Treasure Island, FL: StatPearls Publishing 2023.

[101]
Rawish E, Stiermaier T, Santoro F, Brunetti N, Eitel I. Current knowledge and future challenges in takotsubo syndrome: Part 1-pathophysiology and diagnosis. J Clin Med  2021; 10(3): 479.
 [http://dx.doi.org/10.3390/jcm10030479] [PMID: 33525539]

[102]
Elhendy A, Bax JJ, Poldermans D. Dobutamine stress myocardial perfusion imaging in coronary artery disease. J Nucl Med  2002; 43(12): 1634-46.
 [PMID: 12468513]

[103]
Komamura K, Fukui M, Iwasaku T, Hirotani S, Masuyama T. Takotsubo cardiomyopathy: Pathophysiology, diagnosis and treatment. World J Cardiol  2014; 6(7): 602-9.
 [http://dx.doi.org/10.4330/wjc.v6.i7.602] [PMID: 25068020]

[104]
Yang L, Zhang Y, Hu Y, Yang Z. Pheochromocytoma with Takotsubo Syndrome and acute heart failure: A case report. World J Surg Oncol  2022; 20(1): 251.
 [http://dx.doi.org/10.1186/s12957-022-02704-0] [PMID: 35932074]

[105]
Lyon AR, Citro R, Schneider B, et al. Pathophysiology of takotsubo syndrome. J Am Coll Cardiol  2021; 77(7): 902-21.
 [http://dx.doi.org/10.1016/j.jacc.2020.10.060] [PMID: 33602474]

[106]
Akashi YJ, Nef HM, Lyon AR. Epidemiology and pathophysiology of Takotsubo syndrome. Nat Rev Cardiol  2015; 12(7): 387-97.
 [http://dx.doi.org/10.1038/nrcardio.2015.39] [PMID: 25855605]

[107]
Zhou B, Shi X, Tang X, et al. Functional isolation, culture and cryopreservation of adult human primary cardiomyocytes. Signal Transduct Target Ther  2022; 7(1): 254-70.
 [http://dx.doi.org/10.1038/s41392-022-01044-5] [PMID: 35882831]

[108]
Ong GJ, Nguyen TH, Surikow SY, Horowitz JD. Risk factors for a broken heart: Understanding drug-induced causes for Takotsubo syndrome and pharmacological treatment options. Expert Rev Clin Pharmacol  2022; 15(9): 1017-25.
 [http://dx.doi.org/10.1080/17512433.2022.2121701] [PMID: 36093865]

[109]
Zhang ZY, Sun JJ, Wang JH, et al. Successful treatment of a severe Takotsubo syndrome case complicated by liver abscess. BMC Cardiovasc Disord  2023; 23(1): 189.
 [http://dx.doi.org/10.1186/s12872-023-03145-7] [PMID: 37038117]

[110]
Jing C, Wang Y, Kang C, Dong D, Zong Y. Clinical features of patients with septic shock-triggered Takotsubo syndrome: A single-center 7 case series. BMC Cardiovasc Disord  2022; 22(1): 340.
 [http://dx.doi.org/10.1186/s12872-022-02787-3] [PMID: 35906556]

[111]
Sattar Y, Siew KSW, Connerney M, Ullah W, Alraies C. Management of takotsubo syndrome: A comprehensive review. Cureus  2020; 12(1): e6556.
 [http://dx.doi.org/10.7759/cureus.6556] [PMID: 32042529]

[112]
Santoro F, Ieva R, Ferraretti A, et al. Safety and feasibility of levosimendan administration in takotsubo cardiomyopathy: A case series. Cardiovasc Ther  2013; 31(6): e133-7.
 [http://dx.doi.org/10.1111/1755-5922.12047] [PMID: 24119220]

[113]
Ghadri JR, Wittstein IS, Prasad A, et al. International expert consensus document on takotsubo syndrome (Part II): Diagnostic workup, outcome, and management. Eur Heart J  2018; 39(22): 2047-62.
 [http://dx.doi.org/10.1093/eurheartj/ehy077] [PMID: 29850820]

[114]
de Gregorio C, Grimaldi P, Lentini C. Left ventricular thrombus formation and cardioembolic complications in patients with Takotsubo-like syndrome: A systematic review. Int J Cardiol  2008; 131(1): 18-24.
 [http://dx.doi.org/10.1016/j.ijcard.2008.05.060] [PMID: 18692258]

[115]
Lau C, Chiu S, Nayak R, Lin B, Lee MS. Survival and risk of recurrence of takotsubo syndrome. Heart  2021; 107(14): 1160-6.
 [http://dx.doi.org/10.1136/heartjnl-2020-318028] [PMID: 33419884]
Cite As
Current Cardiology Reviews

Pharmacological Triggers of Takotsubo Cardiomyopathy: An Updated Review of Evidence and Recommendations

Abstract

Graphical Abstract
